Title

Estrogen and Progesterone Receptor Testing in Breast Cancer

Authoring Organizations

American Society of Clinical Oncology

American Society of Cytopathology

College of American Pathologists

Publication Month/Year

January 13, 2020

Last Updated Month/Year

November 7, 2024

Document Type

Guideline

External Publication Status

Published

Country of Publication

US

Document Objectives

To update key recommendations of the American Society of Clinical Oncology/College of American Pathologists estrogen (ER) and progesterone receptor (PgR) testing in breast cancer guideline

Target Patient Population

Patients with breast cancer.

Target Provider Population

Medical oncologists, pathologists, surgeons, radiation oncologists

PICO Questions

  1. What additional strategies can promote optimal performance, interpretation, and reporting of immunohistochemistry (IHC) assays, particularly in cases with low estrogen receptor (ER) expression?

  2. Are other ER expression assays acceptable for identifying patients likely to benefit from endocrine therapy?

  3. What are the optimum quality assurance (QA), tissue handling, scoring system, and reporting for determining potential benefit from endocrine therapy?

  4. Should ductal carcinoma in situ (DCIS) be routinely tested for hormone receptors?

Inclusion Criteria

Female, Adult, Older adult

Health Care Settings

Ambulatory, Hospital, Laboratory services, Outpatient

Intended Users

Nurse, nurse practitioner, physician, physician assistant

Scope

Diagnosis, Assessment and screening

Diseases/Conditions (MeSH)

D011960 - Receptors, Estrogen, D011374 - Progesterone, D011980 - Receptors, Progesterone

Keywords

breast cancer, estrogen, progesterone, cancer, estrogen receptor, progesterone receptors, testing, Breast Cancer

Source Citation

Allison KH, Hammond MEH, Dowsett M, McKernin SE, Carey LA, Fitzgibbons PL, Hayes DF, Lakhani SR, Chavez-MacGregor M, Perlmutter J, Perou CM, Regan MM, Rimm DL, Symmans WF, Torlakovic EE, Varella L, Viale G, Weisberg TF, McShane LM, Wolff AC. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update. J Clin Oncol. 2020 Apr 20;38(12):1346-1366. doi: 10.1200/JCO.19.02309. Epub 2020 Jan 13. PMID: 31928404.

Supplemental Methodology Resources

Data Supplement,